BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

J&J’s single-dose COVID-19 vaccine approved for emergency use in India

In a tweet, Health Minister Mansukh Mandaviya said, now India has five Emergency Use Authorization vaccines. He added that this will further boost the coun...

August 09, 2021 | News

Novavax and SII Announce Submission to Regulatory Agencies in India, Indonesia, Philippines

Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in...

August 06, 2021 | News

Illumina to Support Sequencing-Based COVID-19 Surveillance in India

Illumina, Inc. has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in t...

August 04, 2021 | News

Glenmark,SaNOtize to commercialize Nasal Spray for COVID-19 treatment in Asia

Nitric oxide has antimicrobial properties with direct proven effect on SARS-CoV-2 Nitric Oxide Nasal Spray (NONS) has been tested in healthy volunteers ...

August 03, 2021 | News

Bharat Biotech’s ROTAVAC 5D® Receives WHO Prequalification

Prequalification will fast-track procurement and global access of ROTAVAC 5D® · &nbs...

August 02, 2021 | News

CliniRx to offer full suite of Rave EDC and CDM services to sponsors

CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to furt...

July 30, 2021 | News

EVA Pharma: Supporting India Amid COVID-19 Surge

When India experienced an unexpected COVID-19 surge this spring, the rapid increase in cases put pressure on the local pharmaceutical industry to supply th...

July 27, 2021 | News

Biocon Biologics to Manufacture and Commercialize a Broadly Neutralizing Antibody for India and Select Emerging Markets

Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. , announced today that U.S. based Adagio Therapeutics has gra...

July 26, 2021 | News

Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%

Biocon Ltd , an innovation-led global biopharmaceuticals company, announced its consolidated financial results for the first quarter ended June ...

July 26, 2021 | News

Intas, First Indian company to launch a biosimilar product in the EU

Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreeme...

July 22, 2021 | News

Biological E to purchase CpG 1018 adjuvant from Dynavax

DYNAVAX AND BIOLOGICAL E ANNOUNCE COMMERCIAL SUPPLY AGREEMENT OF DYNAVAX’S CpG 1018 ADJUVANT FOR BIOLOGICAL E’S COVID-19 VACCINE CANDIDATE Dyn...

July 06, 2021 | News

DCGI has approved biotechnology Panacea Biotech to manufacture Sputnik V in India.

The license is a necessary condition for using Sputnik V produced by Panacea Biotec in India. The batches produced at Panacea Biotec’s faciliti...

July 05, 2021 | News

India cleared the 4th vaccine for emergency use in the country, the US-made Moderna.

Mumbai-based pharma major Cipla has been allowed to import Moderna's Covid vaccine for restricted emergency use in India, where the vaccines used so far we...

June 30, 2021 | News

With Serum Institute as a partner, Novavax is poised to launch in India.

The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...

June 16, 2021 | News

Stay Connected